Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1976 Nov 6;115(9):892–894.

Long-term therapy of essential tremor with propranolol.

T J Murray
PMCID: PMC1879108  PMID: 791468

Abstract

In a double-blind crossover study 12 patients with essential tremor were treated with propranolol and a placebo; 8 improved with propranolol and 3 with the placebo; the degree of improvement with propranolol was greater. In a similar study with diazepam 5 of 12 improved with diazepam and 4 of 12 with the placebo; the degree of improvement was less than that achieved with propranolol. Response in 21 patients to treatment with propranolol for 2 to 4 years was excellent in 4, good in 4 and fair in 10; the condition of 1 was unchanged and that of 2, worse. Excellent response was maintained for as long as 4 years, but response tended to deteriorate with time if initially it was less than excellent. Response decreased with increasing age. No patient 60 years of age or older had an excellent response, and the four with an excellent response were under age 55, three being under age 35; all four had had their tremor less than 12 years. Patients with essential tremor should be given a 3-month trial of propranolol at 120 mg/d; if no significant response is seen the dose should be decreased, then the drug discontinued.

Full text

PDF
892

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman E. L., Coltart D. J., Wettach G. E., Harrison D. C. Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med. 1974 Nov;81(5):625–627. doi: 10.7326/0003-4819-81-5-625. [DOI] [PubMed] [Google Scholar]
  2. Anctil R., Hugues F. C., Marche J. Action du propranolol sur la conduction nerveuse chez l'homme. Premiers résultats dans la tétanie chronique idiopathique de l'adulte (spasmophilie) Therapie. 1970 May-Jun;25(3):579–591. [PubMed] [Google Scholar]
  3. Ashenhurst E. M. The nature of essential tremor. Can Med Assoc J. 1973 Nov 3;109(9):876–878. [PMC free article] [PubMed] [Google Scholar]
  4. Bach J. F., Dardenne M. pH and rosette formation. Lancet. 1972 Mar 18;1(7751):633–633. doi: 10.1016/s0140-6736(72)90429-1. [DOI] [PubMed] [Google Scholar]
  5. Balla J. I. Treatment of essential tremor with propranolol. Lancet. 1973 Jan 27;1(7796):205–205. doi: 10.1016/s0140-6736(73)90039-1. [DOI] [PubMed] [Google Scholar]
  6. Barbeau A. Traitement du tremblement essentiel familial par le propanolol. Union Med Can. 1973 Apr;102(4):899–902. [PubMed] [Google Scholar]
  7. Bonn J. A., Turner P. D-Propranolol and anxiety. Lancet. 1971 Jun 26;1(7713):1355–1356. doi: 10.1016/s0140-6736(71)91915-5. [DOI] [PubMed] [Google Scholar]
  8. Drew L. R., Moon J. R., Buchanan F. H. Inderal (propranolol) in the treatment of alcoholism. Med J Aust. 1973 Aug 11;2(6):282–285. doi: 10.5694/j.1326-5377.1973.tb128829.x. [DOI] [PubMed] [Google Scholar]
  9. Dupont E., Hansen H. J., Dalby M. A. Treatment of benign essential tremor with propranolol. A controlled clinical trial. Acta Neurol Scand. 1973;49(1):75–84. doi: 10.1111/j.1600-0404.1973.tb01280.x. [DOI] [PubMed] [Google Scholar]
  10. Gibberd M. G., Staffurth J. S. Oxprenolol in thyrotoxicosis. Lancet. 1973 Jan 27;1(7796):205–205. doi: 10.1016/s0140-6736(73)90038-x. [DOI] [PubMed] [Google Scholar]
  11. Gilligan B. S., Veale J. L., Wodak J. Propranolol in the treatment of tremor. Med J Aust. 1972 Feb 12;1(7):320–322. doi: 10.5694/j.1326-5377.1972.tb46801.x. [DOI] [PubMed] [Google Scholar]
  12. Gilligan B. Propranolol in essential tremor. Lancet. 1972 Nov 4;2(7784):980–980. doi: 10.1016/s0140-6736(72)92520-2. [DOI] [PubMed] [Google Scholar]
  13. Growdon J. H., Shahani B. T., Young R. R. The effect of alcohol on essential tremor. Neurology. 1975 Mar;25(3):259–262. doi: 10.1212/wnl.25.3.259. [DOI] [PubMed] [Google Scholar]
  14. Hebb A. R., Godwin T. F., Gunn R. W. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris. Can Med Assoc J. 1968 Feb 3;98(5):246–251. [PMC free article] [PubMed] [Google Scholar]
  15. Kirk L., Baastrup P. C., Schou M. Letter: Propranolol treatment of lithium-induced tremor. Lancet. 1973 Nov 10;2(7837):1086–1087. doi: 10.1016/s0140-6736(73)92692-5. [DOI] [PubMed] [Google Scholar]
  16. Kissel P., Tridon P., André J. M. Letter: Levodopa-propranolol therapy in parkinsonian tremor. Lancet. 1974 Mar 9;1(7854):403–404. doi: 10.1016/s0140-6736(74)93165-1. [DOI] [PubMed] [Google Scholar]
  17. MARSHALL J. Observations on essential tremor. J Neurol Neurosurg Psychiatry. 1962 May;25:122–125. doi: 10.1136/jnnp.25.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morgan M. H., Hewer R. L., Cooper R. Effect of the beta adrenergic blocking agent propranolol on essential tremor. J Neurol Neurosurg Psychiatry. 1973 Aug;36(4):618–624. doi: 10.1136/jnnp.36.4.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Murray T. J. Treatment of essential tremor with propranolol. Can Med Assoc J. 1972 Nov 18;107(10):984–986. [PMC free article] [PubMed] [Google Scholar]
  20. Scopa J., Longley B. P., Foster J. B. Beta-adrenergic blockers in benign essential tremor. Curr Ther Res Clin Exp. 1973 Feb;15(2):48–51. [PubMed] [Google Scholar]
  21. Shanks R. G., Hadden D. R., Lowe D. C., McDevitt D. G., Montgomery D. A. Controlled trial of propranolol in thyrotoxicosis. Lancet. 1969 May 17;1(7603):993–994. doi: 10.1016/s0140-6736(69)91797-8. [DOI] [PubMed] [Google Scholar]
  22. Sweet R. D., Blumberg J., Lee J. E., Mc Dowell F. H. Propranolol treatment of essential tremor. Neurology. 1974 Jan;24(1):64–67. doi: 10.1212/wnl.24.1.64. [DOI] [PubMed] [Google Scholar]
  23. Weber R. B., Reinmuth O. M. The treatment of migraine with propranolol. Neurology. 1972 Apr;22(4):366–369. doi: 10.1212/wnl.22.4.366. [DOI] [PubMed] [Google Scholar]
  24. Winkler G. F., Young R. R. The control of essential tremor by propranolol. Trans Am Neurol Assoc. 1971;96:66–68. [PubMed] [Google Scholar]
  25. Yorkston N. J., Zaki S. A., Malik M. K., Morrison R. C., Havard C. W. Propranolol in the control of schizophrenic symptoms. Br Med J. 1974 Dec 14;4(5945):633–635. doi: 10.1136/bmj.4.5945.633. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES